FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 33.80
+0.70 (2.11%)
Feb 10, 2026, 4:46 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 552.61 million as of February 10, 2026. Its market cap has decreased by -15.30% in one year.
Market Cap
552.61M
Enterprise Value
573.58M
Revenue
-703.14K
Ranking
n/a
PE Ratio
n/a
Stock Price
33.80
Market Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 552.61M, an increase of 1,280.74%. That is a compound annual growth rate of 47.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 541.16M | -3.50% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SynAct Pharma AB | 1.16B |
| Xspray Pharma AB | 968.42M |
| Oncopeptides AB | 755.40M |
| Infant Bacterial Therapeutics AB | 672.90M |
| Corline Biomedical AB | 409.82M |
| Ascelia Pharma AB | 353.96M |
| Mendus AB | 315.97M |
| Intervacc AB | 313.21M |